5
Disclosures
Feb 12, 2026 — May 12, 2026
Date Range
GROWTH
Market Segment
Pharmaceutical
Sector

Disclosures

DateTypeHeadlinePDF
May 12 Other Immuno-Biological Laboratories Labs Sets New Board After Transition to Audit Committee Firm PDF
May 12 Dividend Immuno-Biological Laboratories Declares Dividend of 6 Per Share PDF
Mar 17 Legal Immuno-Biological Laboratories Labs to Transition to Audit Committee Firm in June 2026 PDF
Feb 16 Other Immuno-Biological Labs Secures Korean Patent for HIV Antibody Method PDF
Feb 12 Earnings Immuno-Biological Laboratories Co., Ltd. Reports Q3 Revenue of 742 million, Up 9% PDF

Disclosure Types

Other: 2 Dividend: 1 Legal: 1 Earnings: 1